Phase III - Biobanking.com

Home Tags Phase III

BrainStorm Cell Therapeutics Passes Safety Milestone In Phase 3 Trial Of NurOwn® Therapy for...

News Stories David Orchard-Webb, PhD

BrainStorm Cell Therapeutics Inc., founded in 2004, based in New York City, is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company...

⭐ Recently Featured

Automated Biobanking: Advantages, Benefits and Future Directions

Automated Biobanking: Advantages, Benefits and Future Directions

Ultra-low Temperature Freezers Have Become Important for Today’s Cell and Gene Therapies

Ultra-low Temperature Freezers Have Become Important for Today’s Cell and Gene Therapies

Cryopreservation

Sample lifecycle in a human biobank

Utilizing Modular Biobanking Software in Different Types of Biobanking Activities

Data & Informatics

Meet ISO 20387 Requirements with a Laboratory Software for Biobanking

ISO 20387:2018: The Key to Quality Biobanking

Ethical & Legal & Societal

Stem Cell Banking: Current Trends, Benefits, Emerging Issues and Challenges

Stem Cell Banking: Current Trends, Benefits, Emerging Issues and Challenges

🔥 Popular Posts

Biobank Profiles

10 Largest Biobanks in the World

Biobanking LIMS Softwares

10 Top Laboratory Information Management Systems (LIMS Softwares) for Biobanking

Data & Informatics

Biobank Facilities

Biobank versus Biorepository: What’s in a Name?

Insights & Opinions

Biobanks can comply with regulatory requirements by following ISBER Best Practices.

Biobanking Science: ISBER Best Practices for Biobanks

Biopreservation Science

Biobank Graz

Biobank Profiles

X